Busch MP - Search Results

1

Estimating blood donor loss due to the variant CJD travel deferral.

Murphy EL, David Connor J, McEvoy P, Hirschler N, Busch MP, Roberts P, Nguyen KA, Reich P. Murphy EL, et al. Among authors: busch mp. Transfusion. 2004 May;44(5):645-50. doi: 10.1111/j.1537-2995.2004.03307.x. Transfusion. 2004. PMID: 15104643

2

Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.

Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, Nelles M, Lee S, Page E, Wilber J, Polito A. Kleinman S, et al. Transfusion. 1992 Nov-Dec;32(9):805-13. doi: 10.1046/j.1537-2995.1992.32993110750.x. Transfusion. 1992. PMID: 1471243

3

Identification of HIV-infected transfusion recipients: the utility of crossreferencing previous donor records with AIDS case reports.

Samson S, Busch M, Ward J, Garner J, Salk S, Fernando L, Holland P, Rutherford G, Benjamin R, Perkins H. Samson S, et al. Transfusion. 1990 Mar-Apr;30(3):214-8. doi: 10.1046/j.1537-2995.1990.30390194339.x. Transfusion. 1990. PMID: 2315995

4

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.

Petersen LR, Satten GA, Dodd R, Busch M, Kleinman S, Grindon A, Lenes B. Petersen LR, et al. Transfusion. 1994 Apr;34(4):283-9. doi: 10.1046/j.1537-2995.1994.34494233574.x. Transfusion. 1994. PMID: 8178324

5

Quantitation of residual WBCs in filtered blood components by high-throughput, real-time kinetic PCR.

Lee TH, Wen L, Chrebtow V, Higuchi R, Watson RM, Sninsky JJ, Busch MP. Lee TH, et al. Among authors: busch mp. Transfusion. 2002 Jan;42(1):87-93. doi: 10.1046/j.1537-2995.2002.00009.x. Transfusion. 2002. PMID: 11896318

6

Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.

Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP; Viral Activation Transfusion Study Group. Asmuth DM, et al. Among authors: busch mp. Transfusion. 2003 Apr;43(4):451-8. doi: 10.1046/j.1537-2995.2003.00350.x. Transfusion. 2003. PMID: 12662277 Clinical Trial.

7

Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.

Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. Drew WL, et al. Among authors: busch mp. Transfusion. 2003 Mar;43(3):309-13. doi: 10.1046/j.1537-2995.2003.00337.x. Transfusion. 2003. PMID: 12675714

8

Effect of a national disaster on blood supply and safety: the September 11 experience.

Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH; NHLBI REDS Study Group. Glynn SA, et al. Among authors: busch mp. JAMA. 2003 May 7;289(17):2246-53. doi: 10.1001/jama.289.17.2246. JAMA. 2003. PMID: 12734136

9

Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients.

Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Murphy EL, et al. Among authors: busch mp. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):655-6. doi: 10.1097/00126334-200308150-00019. J Acquir Immune Defic Syndr. 2003. PMID: 12902815 Clinical Trial. No abstract available.

10

Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.

Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP; Viral Activation Transfusion Study Group. Drew WL, et al. Among authors: busch mp. Transfusion. 2003 Oct;43(10):1351-7. doi: 10.1046/j.1537-2995.2003.00520.x. Transfusion. 2003. PMID: 14507264 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters